BRP-180

N/A

Report date: 2025/12/26 09:51:51

Base Information

Drug NameBRP-180
Drug Alias NameBupropion Novel Formulation (Bioron Pharma)Bupropion biphasic modified releaseBRP-180
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors antagonistsDopamine reuptake inhibitors
TargetsAdrenergic receptorsDopamine transporter
Therapy Area/IndicationsNarcolepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBioron Pharma
China Registration ClassN/A

Develop Information

Active CompaniesBioron Pharma
Inactive CompaniesN/A
Active IndicationsNarcolepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A